Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02027961
Title Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors MedImmune LLC
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | CAN

Additional content available in CKB BOOST